5 Top Dividend Stocks to Buy in November

If you invest in stocks that pay dividends, you probably know that it's not a get-rich-quick strategy. Yet dividend stocks can be immensely rewarding. With enough patience and compounding, your dividend income could eventually pay your bills.

It's a slow, steady process, one that I often refer to as a brick-by-brick journey. The good news is that you can almost always find dividend stock deals in the stock market. Look for steady, proven winners with extensive track records of growth and dividend increases.

Here are five blue-chip dividend stocks investors can confidently buy and hold this month.

Image source: Getty Images.

1. Chevron

Oil and gas have powered society for generations. Chevron (NYSE: CVX) is one of the industry's heavyweights, with diverse operations across oil and gas exploration, extraction, refining, and retail. Management has raised the company's dividend annually for 37 consecutive years, demonstrating the company's ability to keep generating profits in what is a volatile energy industry.

We'll need oil and gas for the foreseeable future, and Chevron's recent acquisition of Hess gave it a stake in one of the most significant oil discoveries in decades. Management anticipates the company growing its free cash flow by at least 10% annually through 2030 if oil prices average $70 per barrel. That growth could fund many future dividend hikes, building on the stock's current 4.4% dividend yield.

2. Medtronic

Global medical devices giant Medtronic (NYSE: MDT) is a trusted name across the healthcare industry, with a history dating back to 1949. The company sells a wide range of products used for patients across its three business segments: cardiovascular, surgical, and neuroscience. There is a constant need for innovation to improve treatments and to treat more patients as the global population increases.

Medtronic is about as steady a dividend stock as you'll find. Management has raised the dividend for 47 consecutive years. The business is mature, but the stock offers a solid 2.8% dividend yield. Additionally, Medtronic is preparing to spin off its diabetes segment to help spark growth and just had a strong quarter, making the stock a solid buy at a price-to-earnings ratio of under 18 today.

3. Clorox

Household products company Clorox (NYSE: CLX) has struggled in recent years, with post-pandemic inflation and a disastrous security breach. However, the company has continued to raise its dividend while it works through its issues. It's almost a Dividend King, with 48 consecutive annual dividend increases. On the bright side, the stock's share price woes have cranked the yield up to nearly 5%.

While abnormally high yields are sometimes a sign of a yield trap, Clorox seems ready to get back on its feet. Analysts see Clorox's earnings per share rebounding from an estimated 2025 finish of $6.00 to $6.77 next year. Such a legendary dividend stock looks like a solid bargain at under 15 times 2026 earnings estimates.

4. Colgate-Palmolive

Toothpaste and hand soap giant Colgate-Palmolive (NYSE: CL) is so steady that it's almost boring to watch. However, people never stop using soap and toothpaste, which translates to clockwork-like profits and dividends. Colgate-Palmolive has one of the longest-running dividend growth streaks at 62 years. Remarkably, the dividend payout ratio is still only 57% of 2025 earnings estimates!

That leaves plenty of room to continue hiking that dividend, and investors start at a 2.6% dividend yield. The market may have overlooked Colgate-Palmolive amid the ongoing tech stock craze. Its current price-to-earnings ratio of 22 is near its decade lows. But those who want a dependable dividend with steady single-digit growth can confidently buy and hold this portfolio stalwart.

5. Automatic Data Processing

You generally don't see many dividend growers in the tech space, but Automatic Data Processing (NASDAQ: ADP), ADP for short, is a glaring exception. It's the world's leading provider of cloud-based human capital management software, offering tools for payroll, benefits, compliance, and more. Managing employees and people is something almost every company does. As a result, ADP's business has steadily grown for decades.

It's also a newly crowned Dividend King with 50 consecutive annual dividend hikes. Perhaps the most impressive thing about ADP is that the dividend has sustained double-digit growth, and analysts expect the company's earnings to grow by 10% annually over the next three to five years. Considering the consistent excellence ADP delivers, it's hard not to like the stock at under 23 times 2025 earnings estimates.

Justin Pope has positions in Automatic Data Processing and Clorox. The Motley Fool has positions in and recommends Chevron and Colgate-Palmolive. The Motley Fool recommends Medtronic and recommends the following options: long January 2026 $75 calls on Medtronic and short January 2026 $85 calls on Medtronic. The Motley Fool has a disclosure policy.